Editorial

Published on 05 Jan 2023

Editorial: Crosstalk between thyroid hormones, analogs and ligands of integrin αvβ3 in health and disease. Who is talking now?

in Cancer Endocrinology

Sandra Incerpi
Osnat Ashur-Fabian
Paul J. Davis
Jens Z. Pedersen

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1119952

974 views
1 citation

Original Research

Published on 05 Jan 2023

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

in Cancer Endocrinology

Jingwei Lin
Yingxin Cai
Zuomin Wang
Yuxiang Ma
Jinyou Pan
Yangzhou Liu
Zhigang Zhao

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1005916

4,928 views
7 citations

Original Research

Published on 05 Jan 2023

A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning

in Cancer Endocrinology

Ziye Wang
Chan Xu
Wencai Liu
Meiying Zhang
Jian’an Zou
Mingfeng Shao
Xiaowei Feng
Qinwen Yang
Wenle Li
Xiue Shi

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1083569

7,595 views
5 citations

Editorial

Published on 20 Dec 2022

Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: The way to new therapeutic approaches

in Cancer Endocrinology

Guy Leclercq
Filippo Acconcia

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1094711

1,795 views

Original Research

Published on 20 Dec 2022

Prediction of the invasiveness of PTMC by a combination of ultrasound and the WNT10A gene

in Cancer Endocrinology

Zhang Yan
Liu Wen Gang
Guo Shi Yan
Ping Zhou

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1026059

2,151 views
4 citations

Original Research

Published on 20 Dec 2022

Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making

in Cancer Endocrinology

Yanlong Shi
Yizhu Wang
Rui Yang
Wenning Zhang
Yu Zhang
Kun Feng
Qingpeng Lv
Kaiyi Niu
Jiping Chen
Li Li

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1090324

4,587 views
4 citations

Original Research

Published on 20 Dec 2022

Relationship between serum NDRG3 and papillary thyroid carcinoma

in Cancer Endocrinology

Jiahao Wang
Jun Wang
Jinxing Quan
Juxiang Liu
Limin Tian
Changhong Dong

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1091462

2,248 views
2 citations

Correction

Published on 19 Dec 2022

Corrigendum: A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer

in Cancer Endocrinology

Wenjie Shi
Xiaofeng Huang
Ye Wang
Xinyu Wan
Jinzhi He
Yinggang Xu
Weiwei Zhang
Rui Chen
Lu Xu
Xiaoming Zha

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1109390

863 views

Review

Published on 14 Dec 2022

Role of cystatin C in urogenital malignancy

in Cancer Endocrinology

Li Ding
Zijie Liu
Junqi Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1082871

3,821 views
5 citations

Systematic Review

Published on 13 Dec 2022

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy

in Cancer Endocrinology

Bo Yuan
Jichun Ma
Jing Wang
Jinyong Hao

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1060768

2,205 views
8 citations

Original Research

Published on 12 Dec 2022

X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients

in Cancer Endocrinology

Sandeep Kumar Parvathareddy
Abdul K. Siraj
Rong Bu
Kaleem Iqbal
Maha Al-Rasheed
Wael Al-Haqawi
Padmanaban Annaiyappanaidu
Nabil Siraj
Saeeda O. Ahmed
Saif S. Al-Sobhi

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1054882

1,815 views
2 citations

Original Research

Published on 09 Dec 2022

The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer

in Cancer Endocrinology

Yun-Gang Sun
Fei Chen
Qiao-Ling Sun
Jin-Yu Tian
Xiao-Chuan He

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1026737

2,012 views

Original Research

Published on 08 Dec 2022

Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma

in Cancer Endocrinology

Hao Chi
Gaoge Peng
Jinyan Yang
Jinhao Zhang
Guobin Song
Xixi Xie
Dorothee Franziska Strohmer
Guichuan Lai
Songyun Zhao
Rui Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1056310

4,634 views
43 citations

Review

Published on 08 Dec 2022

Emerging mechanisms progress of colorectal cancer liver metastasis

in Cancer Endocrinology

Wenhu Zhao
Shipeng Dai
Lei Yue
Fan Xu
Jian Gu
Xinzheng Dai
Xiaofeng Qian

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1081585

10,037 views
22 citations

Original Research

Published on 06 Dec 2022

A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study

in Cancer Endocrinology

Yimeng Li
Aimin Jiang
Yujia Zhao
Chuchu Shi
Yuyan Ma
Xiao Fu
Xuan Liang
Tao Tian
Zhiping Ruan
Yu Yao

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1050364

2,285 views
2 citations

Original Research

Published on 05 Dec 2022

Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis

in Cancer Endocrinology

Peixian Zheng
Na Li
Xianquan Zhan

Frontiers in Endocrinology

doi 10.3389/fendo.2022.972341

6,118 views
17 citations

Navigation group

Articles

Editorial: Crosstalk between thyroid hormones, analogs and ligands of integrin αvβ3 in health and disease. Who is talking now?

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning

Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: The way to new therapeutic approaches

Prediction of the invasiveness of PTMC by a combination of ultrasound and the WNT10A gene

Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making

Relationship between serum NDRG3 and papillary thyroid carcinoma

Corrigendum: A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer

Role of cystatin C in urogenital malignancy

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy

X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients

The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer

Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma

Emerging mechanisms progress of colorectal cancer liver metastasis

A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study

Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis